Cargando…
Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase
BACKGROUND: In neuroblastoma, hyperactivation of the PI3K signaling pathway has been correlated with aggressive neuroblastomas, suggesting PI3Ks as promising targets for the treatment of neuroblastoma. However, the oncogenic roles of individual PI3K isoforms in neuroblastoma remain elusive. RESULTS:...
Autores principales: | Guo, Yue, Guo, Donghao, Zhang, Shaoting, Zhang, Yuan, He, Xiaoyan, Jiang, Xiaohua, Chan, Andrew Man-Lok, Zou, Lin, Sun, Jianmin, Zhao, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801621/ https://www.ncbi.nlm.nih.gov/pubmed/36585695 http://dx.doi.org/10.1186/s13578-022-00946-9 |
Ejemplares similares
-
Targeting anaplastic lymphoma kinase in neuroblastoma
por: Umapathy, Ganesh, et al.
Publicado: (2019) -
Anaplastic lymphoma kinase-special immunity and immunotherapy
por: Guo, Ye, et al.
Publicado: (2022) -
Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update
por: Brenner, Annette K., et al.
Publicado: (2021) -
NUMB regulates the endocytosis and activity of the anaplastic lymphoma kinase in an isoform-specific manner
por: Wei, Ran, et al.
Publicado: (2019) -
Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
por: Buchanan, Christina M., et al.
Publicado: (2013)